New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Machine learning model identifies mild cognitive impairment from retinal scans

Machine learning model identifies mild cognitive impairment from retinal scans

by Duke University Medical CenterIllustration of the structure of the convolutional neural network (CNN) for differentiation of eyes of subjects with mild cognitive impairment from cognitively he
Ophthalmology June 14,2024
Machine learning model identifies mild cognitive impairment from retinal scans

Machine learning model identifies mild cognitive impairment from retinal scans

by Duke University Medical CenterIllustration of the structure of the convolutional neural network (CNN) for differentiation of eyes of subjects with mild cognitive impairment from cognitively he
Ophthalmology June 14,2024
Gene mutation may speed up memory loss in Alzheimer's disease

Gene mutation may speed up memory loss in Alzheimer's disease

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A gene mutation may accelerate the loss of memory and thinking skill
Neurology June 14,2024
Gene mutation may speed up memory loss in Alzheimer's disease

Gene mutation may speed up memory loss in Alzheimer's disease

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A gene mutation may accelerate the loss of memory and thinking skill
Neurology June 14,2024
Machine learning model able to detect signs of Alzheimer's across languages

Machine learning model able to detect signs of Alzheimer's across languages

by Adrianna MacPherson,University of AlbertaCredit: Pixabay/CC0 Public DomainResearchers are striving to make earlier diagnosis of Alzheimer's dementia possible with a machine learning (ML)
Neurology June 14,2024
Machine learning model able to detect signs of Alzheimer's across languages

Machine learning model able to detect signs of Alzheimer's across languages

by Adrianna MacPherson,University of AlbertaCredit: Pixabay/CC0 Public DomainResearchers are striving to make earlier diagnosis of Alzheimer's dementia possible with a machine learning (ML)
Neurology June 14,2024
Gene variant may help protect against Alzheimer's disease

Gene variant may help protect against Alzheimer's disease

by Massachusetts General HospitalCredit: CC0 Public DomainA new study led by investigators at Massachusetts General Hospital (MGH), in collaboration with the University of Antioquia, Schepens Eye
Neurology June 14,2024
Gene variant may help protect against Alzheimer's disease

Gene variant may help protect against Alzheimer's disease

by Massachusetts General HospitalCredit: CC0 Public DomainA new study led by investigators at Massachusetts General Hospital (MGH), in collaboration with the University of Antioquia, Schepens Eye
Neurology June 14,2024
The genome guardian turns to the dark side: Opportunity for drug discovery against cancer?

The genome guardian turns to the dark side: Opportunity for drug discovery against cancer?

by Publicase Comunicação CientíficaUnder normal conditions, native p53 protein is folded but when chemicals and/or high pressure are applied the protein may unfold and loose its 3D structure. Dur
Neurology June 14,2024
The genome guardian turns to the dark side: Opportunity for drug discovery against cancer?

The genome guardian turns to the dark side: Opportunity for drug discovery against cancer?

by Publicase Comunicação CientíficaUnder normal conditions, native p53 protein is folded but when chemicals and/or high pressure are applied the protein may unfold and loose its 3D structure. Dur
Neurology June 14,2024
Ancient DNA reveals reason for high multiple sclerosis and Alzheimer's rates in Europe

Ancient DNA reveals reason for high multiple sclerosis and Alzheimer's rates in Europe

by University of CambridgeThe new study has found the genes that significantly increase a person's risk of developing multiple sclerosis (MS) were introduced into north-western Europe around
Neurology June 14,2024
Ancient DNA reveals reason for high multiple sclerosis and Alzheimer's rates in Europe

Ancient DNA reveals reason for high multiple sclerosis and Alzheimer's rates in Europe

by University of CambridgeThe new study has found the genes that significantly increase a person's risk of developing multiple sclerosis (MS) were introduced into north-western Europe around
Neurology June 14,2024
Nature vs nurture: Twin study sheds light on heritable brain activity

Nature vs nurture: Twin study sheds light on heritable brain activity

by University of New South WalesCredit:Human Brain Mapping(2024). DOI: 10.1002/hbm.26557The way our brain processes different emotional and cognitive tasks may be underpinned by commo
Neurology June 14,2024
Nature vs nurture: Twin study sheds light on heritable brain activity

Nature vs nurture: Twin study sheds light on heritable brain activity

by University of New South WalesCredit:Human Brain Mapping(2024). DOI: 10.1002/hbm.26557The way our brain processes different emotional and cognitive tasks may be underpinned by commo
Neurology June 14,2024
Analysis identifies more than 275 million previously unreported genetic variations

Analysis identifies more than 275 million previously unreported genetic variations

by Bill Snyder,Vanderbilt University Medical CenterTimeline and process overview. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02796-zAn analysis of genomic data from nearly
Family Medicine June 14,2024
Analysis identifies more than 275 million previously unreported genetic variations

Analysis identifies more than 275 million previously unreported genetic variations

by Bill Snyder,Vanderbilt University Medical CenterTimeline and process overview. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-02796-zAn analysis of genomic data from nearly
Family Medicine June 14,2024
Investigators explore what factors increase susceptibility to COVID-19

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente
Public Health & Prevention June 14,2024
Investigators explore what factors increase susceptibility to COVID-19

Investigators explore what factors increase susceptibility to COVID-19

by Cedars-Sinai Medical CenterHeritability and shared environment estimates over time for SARS-CoV-2 susceptibility. a) Cumulative heritability and shared environment estimates with 95% CI. Cente
Public Health & Prevention June 14,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com